Voogd A C, Rodrigus P T, Crommelin M A, Repelaer van Driel O J, Roukema J A, Coebergh J W
Integraal Kankercentrum Zuid, Eindhoven.
Ned Tijdschr Geneeskd. 1995 Nov 25;139(47):2422-7.
To evaluate the treatment and prognosis of 82 patients with local relapse in the breast as the first event after breast-conserving therapy of operable breast cancer.
Descriptive and retrospective.
17 general hospitals in southeast North-Brabant and North-Limburg.
Using the registries of the Comprehensive Cancer Centre South in Eindhoven (1981-1990) and the Bernard Verbeeten Institute in Tilburg (1981-1987), 82 patients were identified who had developed local recurrence after breast-conserving therapy.
The mean age of the 82 patients at the time of detection of local recurrence was 51 years. 46 recurrences (56%) were localized at or near the site of the original tumour, 14 (17%) were detected elsewhere in the breast, 15 (18%) showed diffuse spread through the breast and seven (9%) were completely or partly localized in the skin. Nine recurrences (11%) were non-invasive. Of the 82 patients four received adjuvant systemic therapy only and no surgery. Of the 78 patients treated with surgery 72 underwent mastectomy, 6 local excision. After treatment, the actuarial five-year overall survival, distant recurrence-free survival and disease-free survival rates were 60%, 43% and 31% respectively. Local control, defined as survival without second local recurrence and without local progression of the disease, was 57% after five years.
The five-year distant recurrence-free and disease-free survival rates for patients with local recurrence after breast conserving-therapy were low. The high proportion of second local recurrences and local progression of disease in this study underlines the difficulty of obtaining local control after treatment of local recurrence.
评估82例可手术乳腺癌保乳治疗后首次出现局部复发的患者的治疗情况及预后。
描述性回顾研究。
北布拉班特省东南部和北林堡省的17家综合医院。
利用埃因霍温市南部综合癌症中心(1981 - 1990年)和蒂尔堡市伯纳德·韦尔贝滕研究所(1981 - 1987年)的登记资料,确定82例保乳治疗后出现局部复发的患者。
82例患者局部复发时的平均年龄为51岁。46例复发(56%)位于原肿瘤部位或其附近,14例(17%)在乳房其他部位被检测到,15例(18%)显示在乳房内弥漫性扩散,7例(9%)完全或部分局限于皮肤。9例复发(11%)为非侵袭性。82例患者中4例仅接受辅助性全身治疗而未接受手术。在接受手术治疗的78例患者中,72例行乳房切除术,6例行局部切除术。治疗后,精算的五年总生存率、远处无复发生存率和无病生存率分别为60%、43%和31%。局部控制定义为无二次局部复发且疾病无局部进展的生存,五年后为57%。
保乳治疗后局部复发患者的五年远处无复发生存率和无病生存率较低。本研究中二次局部复发和疾病局部进展的高比例凸显了治疗局部复发后实现局部控制的困难。